T1	TestArticle 40 44	ROFA
T2	EndpointUnitOfMeasure 122 124	mb
T3	TestArticle 144 148	ROFA
T4	TestArticle 286 290	ROFA
T5	TestArticle 371 375	TiO2
T6	TestArticle 444 448	ROFA
T7	TestArticle 482 486	ROFA
T8	TestArticle 491 495	TiO2
T9	Vehicle 525 539	sterile saline
T10	DoseRoute 573 577	IT i
T11	DoseRoute 586 588	on
T12	Sex 614 618	Male
T13	Strain 619 633	Sprague Dawley
T14	Species 634 638	rats
T15	DoseRoute 1098 1102	IT i
T16	DoseRoute 1111 1113	on
T17	Species 1116 1120	Rats
T18	DoseRoute 1153 1159	intrap
T19	DoseRoute 1161 1183	itoneal (ip) injection
T20	TestArticle 1204 1206	ol
T21	DoseRoute 1211 1213	IT
T22	DoseRoute 1218 1223	illed
T23	TestArticle 1229 1233	ROFA
T24	Dose 1235 1238	0.1
T25	Dose 1242 1246	0.25
T26	DoseUnits 1247 1250	mg/
T27	Species 1250 1253	rat
T28	Endpoint 1401 1407	endoth
T29	Endpoint 1409 1441	ium-dependent arteriolar dilatio
T30	Endpoint 1446 1457	the rat spi
T31	Endpoint 1458 1465	otrapez
T32	Endpoint 1466 1475	us muscle
T33	Species 1502 1506	Rats
T34	GroupName 1514 1535	vehicle control group
T35	DoseRoute 1541 1543	IT
T36	Dose 1555 1558	300
T37	DoseUnits 1559 1561	 L
T38	Vehicle 1562 1576	sterile saline
T39	Species 1578 1582	Rats
T40	GroupName 1590 1612	particle control group
T41	TestArticle 1629 1633	TiO2
T42	Dose 1635 1638	0.1
T43	Dose 1642 1646	0.25
T44	DoseUnits 1647 1650	mg/
T45	Species 1650 1653	rat
T46	DoseRoute 1662 1672	IT instill
T47	Endpoint 1674 1677	ion
T48	Species 1683 1687	rats
T49	Endpoint 1720 1729	histology
T50	Endpoint 1734 1738	intr
T51	Endpoint 1742 1755	al microscopy
T52	Endpoint 1784 1824	BAL samples for measurement of pulmonary
T53	Endpoint 1827 1832	flamm
T54	Endpoint 1834 1848	ion and damage
T55	Species 1851 1855	Rats
T56	Endpoint 1954 1957	BAL
T57	Vehicle 2022 2036	phosphate-buff
T58	Vehicle 2038 2047	ed saline
T59	Endpoint 2099 2145	BAL fluid lactate dehydrogenase (LDH) activity
T60	Endpoint 2150 2172	albumin protein assays
T61	Endpoint 2175 2237	BAL fluid LDH activities were determined as a marker of cytoto
T62	Endpoint 2240 2256	ity, and albumin
T63	EndpointUnitOfMeasure 2257 2262	conce
T64	EndpointUnitOfMeasure 2267 2271	ions
T65	Endpoint 2433 2472	Alveolar macrophage (AM) chemiluminesce
T66	Endpoint 2473 2480	ce (CL)
T67	Endpoint 2483 2488	AM CL
T68	Endpoint 2565 2580	reactive oxygen
T69	Endpoint 2608 2632	Histology and immunohist
T70	Endpoint 2645 2667	To more thoroughly ide
T71	Endpoint 2671 2682	y pulmonary
T72	Endpoint 2685 2690	flamm
T73	Endpoint 2692 2726	ion, microscopic sections of lungs
T74	Species 2732 2736	rats
T75	Vehicle 2750 2756	saline
T76	Endpoint 2763 2770	osed to
T77	Dose 2771 2774	0.1
T78	DoseUnits 2775 2777	mg
T79	TestArticle 2778 2782	ROFA
T80	Endpoint 2799 2850	Lung tissue sections were evaluated by a board-cert
T81	Endpoint 2852 2906	ied veterinary pathologist for morphologic alterations
T82	Endpoint 2924 2935	e pathology
T83	EndpointUnitOfMeasure 2936 2942	scores
T84	Endpoint 2943 2971	were calculated for alveolar
T85	Endpoint 2975 2979	lamm
T86	Endpoint 3004 3013	pathology
T87	EndpointUnitOfMeasure 3014 3019	score
T88	EndpointUnitOfMeasure 3071 3079	none, mi
T89	EndpointUnitOfMeasure 3080 3119	imal, mild, moderate, marked, or severe
T90	Endpoint 3119 3137	) and distribution
T91	EndpointUnitOfMeasure 3139 3219	none, focal, locally extensive, multifocal, multifocal and coalescent, or severe
T92	Endpoint 3219 3242	) of tissue alterations
T93	Endpoint 3256 3265	pathology
T94	EndpointUnitOfMeasure 3266 3290	score on a scale of 0 10
T95	Endpoint 3366 3379	microvascular
T96	Endpoint 3383 3387	lamm
T97	Endpoint 3389 3392	ion
T98	Endpoint 3394 3446	histologic analysis was performed on the spinotrapez
T99	Endpoint 3447 3456	us muscle
T100	Species 3460 3464	rats
T101	TimeEndpointAssessed 3465 3467	24
T102	TimeUnits 3468 3485	hr after exposure
T103	TestArticle 3489 3493	ROFA
T104	TestArticle 3497 3501	TiO2
T105	Dose 3503 3506	0.1
T106	Dose 3510 3514	0.25
T107	DoseUnits 3515 3517	mg
T108	Species 3575 3578	rat
T109	TestArticle 3683 3692	hematoxyl
T110	Endpoint 3692 3704	in and eosin
T111	Endpoint 3755 3766	ls and eosi
T112	Endpoint 3768 3770	ph
T113	TestArticle 3770 3774	ils.
T114	Endpoint 3792 3807	hemoprotein MPO
T115	Endpoint 3811 3826	the spinotrapez
T116	Endpoint 3827 3836	us muscle
T117	Species 3840 3844	rats
T118	TimeEndpointAssessed 3845 3847	24
T119	TimeUnits 3848 3850	hr
T120	Vehicle 3872 3878	saline
T121	Dose 3882 3886	0.25
T122	DoseUnits 3887 3889	mg
T123	TestArticle 3890 3894	ROFA
T124	Endpoint 3901 3906	ohist
T125	Endpoint 3913 3916	try
T126	Species 4245 4251	rabbit
T127	TestArticle 4265 4270	ibody
T128	Endpoint 4323 4326	MPO
T129	TestArticle 4384 4389	-dole
T130	Endpoint 4537 4551	Reverse transc
T131	Endpoint 4552 4593	iptase polymerase chain reaction (RT-PCR)
T132	Endpoint 4600 4626	left and right spinotrapez
T133	Endpoint 4627 4644	us muscles were e
T134	Endpoint 4648 4650	ed
T135	Species 4656 4660	rats
T136	TimeEndpointAssessed 4661 4663	24
T137	TimeUnits 4664 4666	hr
T138	Vehicle 4688 4694	saline
T139	Dose 4698 4700	0.
T140	Dose 4701 4702	5
T141	DoseUnits 4703 4705	mg
T142	TestArticle 4706 4710	ROFA
T143	Endpoint 4716 4833	the microcirculation was dissected from the surrounding skeletal muscle. The pooled microvascular samples from an ind
T144	Endpoint 4838 4840	al
T145	Species 4841 4844	rat
T146	Endpoint 4845 4910	were stored in RNAlater (Ambion, Austin, TX) at 4 C for total RNA
T147	Endpoint 4922 4931	Total RNA
T148	TestArticle 4968 4972	o-sc
T149	Species 5103 5107	Rats
T150	Endpoint 5253 5264	ated to ens
T151	Endpoint 5340 5357	arterial pressure
T152	Endpoint 5363 5380	right spinotrapez
T153	Endpoint 5381 5405	us muscle was then exter
T154	Endpoint 5408 5495	ized, superfused with an electrolyte solution, and prepared for microscopic observation
T155	Endpoint 5724 5750	arteriolar inner diameters
T156	Endpoint 5765 5795	and venular leukocyte adhesion
T157	TestArticle 5807 5811	ied.
T158	Endpoint 5851 5863	Arteriolar e
T159	Endpoint 5865 5868	oth
T160	Endpoint 5870 5892	ium-dependent dilation
T161	Endpoint 5940 5949	+-depende
T162	Endpoint 6571 6605	passive diameter of each arteriole
T163	Endpoint 6641 6658	arteriolar respon
T164	Endpoint 6660 6679	veness to adrenergi
T165	Endpoint 6701 6703	ph
T166	Species 6772 6776	rats
T167	Vehicle 6802 6808	saline
T168	Dose 6812 6814	0.
T169	TestArticle 6820 6824	ROFA
T170	Endpoint 7418 7471	Adhering or rolling leukocytes in first-order venules
T171	Species 7475 7479	rats
T172	Vehicle 7505 7511	saline
T173	Dose 7513 7517	0.25
T174	DoseUnits 7518 7520	mg
T175	TestArticle 7521 7525	ROFA
T176	Dose 7530 7533	0.1
T177	DoseUnits 7534 7536	mg
T178	TestArticle 7537 7541	TiO2
T179	Endpoint 7574 7589	microvascular i
T180	Endpoint 7590 7595	flamm
T181	Endpoint 7602 7612	Leukocytes
T182	EndpointUnitOfMeasure 7722 7729	counted
T183	Endpoint 7778 7817	Oxidant activity in the arteriolar wall
T184	Endpoint 7926 7939	microvascular
T185	Endpoint 7942 7954	idant stress
T186	Endpoint 8045 8056	spinotrapez
T187	Endpoint 8057 8105	us muscle was fixed with a 10% formalin solution
T188	Endpoint 8119 8174	The tissue was then viewed with bright-field microscopy
T189	Endpoint 8363 8365	as
T190	Endpoint 8423 8460	microvascular wall levels of formazan
T191	Endpoint 8519 8534	xidant activity
T192	EndpointUnitOfMeasure 8632 8643	A = ln(l/l)
T193	Endpoint 8723 8725	as
T194	Endpoint 8743 8802	amount of formazan formed is proportional to the level of o
T195	Endpoint 8803 8817	idant activity
T196	EndpointUnitOfMeasure 8840 8850	absorption
T197	Endpoint 8966 8985	Arteriolar diameter
T198	Endpoint 9039 9044	Resti
T199	Endpoint 9045 9058	g vascular to
T200	EndpointUnitOfMeasure 9104 9136	tone = [(Dpass - D)/Dpass]   100
T201	EndpointUnitOfMeasure 9392 9394	mb
T202	EndpointUnitOfMeasure 9434 9436	mb
T203	Species 9442 9446	rats
